Christina Chaivorapol
About Christina Chaivorapol
Christina Chaivorapol serves as the Vice President of Translational Technologies at Sana Biotechnology, Inc., where she has worked since 2019. She has extensive experience in bioinformatics and genomics, with a strong focus on safety strategies and risk assessment for gene therapy products.
Current Role at Sana Biotechnology
Christina Chaivorapol serves as the Vice President of Translational Technologies at Sana Biotechnology, Inc. since 2019. In this role, she focuses on advancing therapeutic candidates through the product lifecycle stages, particularly in the areas of gene and cell therapy. Her responsibilities include leading company-wide data strategy initiatives and overseeing the development and application of transformative technologies. Chaivorapol's expertise in safety strategies and risk assessment for cell and gene therapy products is integral to her work.
Previous Experience at Roche
Prior to her current position, Christina Chaivorapol worked at Roche as the Research Group Leader (Director) in Bioinformatics, Immunology, and Human Genetics from 2014 to 2017. In this capacity, she contributed to Roche Sequencing Solutions, where she developed strategies for genomic stability and product purity. Her leadership in this role involved managing teams and projects that advanced the understanding of gene therapy products.
Educational Background
Christina Chaivorapol earned her Bachelor of Science degree in Microbiology and Molecular Genetics and Computer Science from the University of California, Los Angeles. She furthered her education at the University of California, San Francisco, where she obtained a Ph.D. in Bioinformatics, Genomics, and Stem Cells. Her academic background laid the foundation for her extensive career in biotechnology and genomics.
Career Development and Internships
Christina Chaivorapol's career began with internships at The Johns Hopkins University and Genentech in 2001 and 2008, respectively. These early experiences provided her with valuable insights into research and development in the biotechnology field. Additionally, she served as a National Science Foundation Fellow at the University of California, San Francisco from 2002 to 2008, further enhancing her expertise in bioinformatics and genomics.
Leadership in Scientific Teams
Throughout her career, Christina Chaivorapol has successfully built and led highly productive teams comprising over 40 individuals across various scientific disciplines. Her leadership spans genomics, computational biology, software engineering, and gene regulation. Chaivorapol has directly led strategies and prepared documentation for multiple therapeutic candidates, including pre-IND and IND filings, showcasing her ability to navigate complex projects in gene and cell therapy.